A total of 118 recommendations based on expert consensus were published regarding the treatment of hidradenitis suppurativa ...
Penn Medicine used an artificial intelligence tool to find a treatment that aided in saving the life of a patient with ...
The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...
Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic ...
Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...
Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...
The patient has iMCD, which has a poor survival rate and few treatment options but an AI tool searched through 4,000 medications to discover one treatment which may work.
Detailed in a new paper published in NEJM, a group led by researchers at the Perelman School of Medicine at the University of Pennsylvania used an AI technique called machine learning to determine ...
Objectives: The aim of this study is to illustrate the long-term efficacy and safety of etanercept (ETN) and adalimumab (ADA) as first-line therapy in a monocentric cohort of JIA patients. Methods: ...
aFrancis I Proctor Foundation, University of California San Francisco, San Francisco, CA, USA bDepartment of Ophthalmology, University of California San Francisco, San Francisco, CA, USA cDepartment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results